FDA product code CGA: Glucose Oxidase, Glucose
CGA is the FDA product code for glucose oxidase, glucose. It is a Class II device, regulated under 21 CFR 862.1345 and reviewed by the Clinical Chemistry panel. FDA has cleared 401 510(k) submissions under CGA, 8 in the last five years, from 184 different applicants. The average 510(k) review took 129 days (median 92); 679 days on average over the last three years. 1 PMA application cites this product code. FDA has posted 89 recalls for CGA devices, 8 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Glucose Oxidase, Glucose |
| Device class | Class II |
| Regulation | 21 CFR 862.1345 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for CGA
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 2 | 212 |
| 2018 | 2 | 156 |
| 2019 | 2 | 44 |
| 2020 | 2 | 218 |
| 2021 | 1 | 135 |
| 2022 | 1 | 683 |
| 2023 | 4 | 240 |
| 2024 | 2 | 1092 |
| 2026 | 1 | 266 |
Compare with all 510(k) review times · Search every CGA clearance
Top CGA applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Lifescan, Inc. | 21 | 2005-05-20 |
| Boehringer Mannheim Corp. | 17 | 1996-04-17 |
| Apex BioTechnology Corp. | 14 | 2015-08-06 |
| Miles Laboratories, Inc. | 12 | 1987-12-22 |
| Medisense, Inc. | 11 | 1999-07-09 |
179 more applicants have CGA clearances. See the full list in Caduvo.
Most recent CGA clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K252488 | Radiometer Medicals Aps | ABL90 FLEX PLUS System | 2026-05-01 | 266 |
| K210933 | Ysi, Inc. | YSI 2900C Biochemistry Analyzer | 2024-09-30 | 1281 |
| K220328 | Medica Corporation | EasyStat 300 | 2024-07-26 | 903 |
| K223179 | Alere San Diego, Inc. | Cholestech LDX System | 2023-09-20 | 344 |
| K223755 | Abbott Point of Care, Inc. | i-STAT G cartridge with the i-STAT 1 System | 2023-09-11 | 270 |
Recalls for CGA devices
89 product recalls in 62 recall events; 8 initiated in the last five years and 7 still open. Most recent: 2025-05-12.
| Year | Recalls |
|---|---|
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
Frequently asked questions
What is FDA product code CGA?
CGA is the FDA product code for glucose oxidase, glucose. It is a Class II device, regulated under 21 CFR 862.1345 and reviewed by the Clinical Chemistry panel.
What device class is CGA?
Class II, regulation 21 CFR 862.1345. Typical premarket route: 510(k).
How long does a 510(k) take for product code CGA?
Across 401 cleared submissions the average was 129 days from receipt to decision (median 92).
Which companies have the most CGA clearances?
Lifescan, Inc. (21); Boehringer Mannheim Corp. (17); Apex BioTechnology Corp. (14); Miles Laboratories, Inc. (12); Medisense, Inc. (11).
Have CGA devices been recalled?
Yes: 89 product recalls across 62 recall events; the most recent began 2025-05-12.
Next steps
- Run an FDA pathway report with predicate devices for product code CGA
- Run a recall and safety report across every CGA manufacturer
- Watch product code CGA for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times